Treatment of Keratoconus With PALK Versus PK
Launched by INSTITUTO DE OFTALMOLOGÍA FUNDACIÓN CONDE DE VALENCIANA · Dec 5, 2015
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of keratoconus grades III or IV in the Amsler Krumeich classification.
- • Need of surgical procedure
- • No endothelial scar
- • Best corrected visual acuity \<20/40
- • Contact lens intolerance
- • Imagenological map pachymetric acquisition over 90% at 9 mm corneal diameter
- Exclusion Criteria:
- • Contraindication for any of the techniques evaluated.
- • Requiring additional surgical procedures.
- • Diagnostic of other ectasia that were not primary keratoconus.
Trial Officials
Enrique Graue Hernandez, MD, MsC
Study Director
Instituto de Oftalmologia Conde de Valenciana
About Instituto De Oftalmología Fundación Conde De Valenciana
The Instituto de Oftalmología Fundación Conde de Valenciana is a leading clinical research institution dedicated to advancing the field of ophthalmology. With a commitment to innovative research and patient care, the institute focuses on developing and testing new therapies and technologies to improve vision health. Through rigorous clinical trials and collaborations with healthcare professionals, the foundation aims to enhance the understanding of ocular diseases and contribute to the global body of knowledge in ophthalmological science. Its mission is to provide comprehensive eye care while fostering education and training in the ophthalmic community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
